By Deron Hamel A 2,000-per-cent price hike on a medication to treat infantile spasms is “predatory behaviour” on the part of Questcor Pharmaceuticals, and drug companies could hike prices on other seizure medications if policies aren’t put into place, says pediatric neurologist Dr. Carter Snead. Infantile spasms – also called West syndrome – is a…
By Lisa Bailey With involvement at the local, provincial and national level of epilepsy agencies, Paul Raymond has gained new perspective on the realities and challenges for people living with the seizure disorder. Now, as Epilepsy Ontario’s new executive director, he’s energized by the prospect of helping to change the landscape and enhance the lives…
The upcoming Canadian League Against Epilepsy (CLAE) conference will be an opportunity for attendees to learn about the latest discoveries in epilepsy research, says its main organizer. Neurologist Dr. Jorge Burneo, the CLAE’s director of education, says the conference is aimed at bringing together Canada’s epilepsy clinicians and researchers to share information and learn from…
A study undertaken as part of the Ontario Brain Institute’s (OBI’s) EpLink program is seeking to provide help to people living with epilepsy who are also experiencing symptoms of depression. An estimated 30 to 40 per cent of people living with epilepsy experience depression that often goes unrecognized and untreated, says EpUp lead investigator Kathryn…
Sponsor Image 1
Sponsor Image 2
Sponsor Image 3
Sponsor Image 1
Sponsor Image 2
Sponsor Image 3
